NCT02576860View on ClinicalTrials.gov

Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle

PHASE3CompletedINTERVENTIONAL

Enrollment

263

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

February 27, 2017

Study Completion Date

September 5, 2017

Conditions

Rosacea

Interventions

DRUG

CLS001 (Omiganan)

Topical gel

DRUG

Vehicle

Vehicle gel

Trial Locations (47)

Unknown

Fort Smith

Rogers

Manhattan Beach

Oceanside

Washington D.C.

Boynton Beach

Miami

Plainfield

Watertown

Omaha

Verona

New York

Stony Brook

High Point

Raleigh

Winston-Salem

Fort Washington

Charleston

Arlington

San Antonio

Phillip

Kogarah

Liverpool

Box Hill

Surrey

Courtice

Peterborough

Windsor

Grenoble

Nantes

Quimper

Berlin

Bochum

Bonn

Cologne

Friedrichshafen

Hamburg

Lingen

Mönchengladbach

Osnabrück

Schweinfurt

Nijmegen

Auckland

Halmstad

Bradford

Birmingham

London

All Listed Sponsors

lead

Maruho Co., Ltd.

INDUSTRY

NCT02576860 - Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle | Biotech Hunter | Biotech Hunter